// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Diagnostic Performance of Virtual FFR derived from routine Coronary Angiography using 1D Flow Modelling: Validation against Fractional Flow Reserve

Kevin Mohee - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: insights from an international multicenter registry

Satoru Mitomo - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary artery lesions

N/A

Outcomes by Total Stent Length in ACS PCI with Second Generation Drug-Eluting Stents: Results from the PROMETHEUS Study

Asha Mahajan - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Associations between Stent Diameter and Clinical Outcomes in ACS PCI Using Second Generation Drug-Eluting Stents: From the PROMETHEUS Study

Abdul Qadeer - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Coronary artery bypass versus percutaneous coronary intervention with second generation drug eluting stents for real world patients with multivessel coronary artery disease

Vasileios Panoulas - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Multi-vessel disease

N/A

Accuracy of the Society of Thoracic Surgeons (STS) Mortality and Stroke Risk Scores for Predicting Outcomes in Patients With Left Main Coronary Artery Disease Undergoing CABG Versus PCI: Insights From the EXCEL Trial

Daniel Thuijs - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Geographical Variation in Anatomical and Procedural Characteristics for Left Main Coronary Artery Revascularization and Their Impact on Clinical Outcomes: Analysis From the EXCEL Trial

Aung Myat - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Outcomes of Patients With and Without Hyperlipidemia Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial

Shmuel Chen - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Outcomes of Patients With Elevated vs. Normal B-Type Natriuretic Peptides After Intervention for Left Main Coronary Artery Disease

Bjorn Redfors - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

Influence of Angina on Outcomes After Revascularization in Patients with Left Main Coronary Artery disease: Insights from the EXCEL Trial

Serge Doucet - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

Prognostic Significance of a Previous Family History of Premature Coronary Artery Disease in Patients with Left Main Disease Undergoing PCI or CABG: Subgroup Analysis from EXCEL Trial

Matias Yudi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Everolimus

Prognostic Significance of Established CAD in Patients with Left Main Disease Undergoing Revascularization: Analysis from EXCEL Trial

Matias Yudi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Sorin Brener - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

Everolimus

Fate of deferred lesions using state-of-art percutaneous coronary revascularization in patients with de novo three vessel disease: lesion level analysis at 2 years of the SYNTAX II study

Norihiro Kogame - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Coronary pressure and flow in patients with severe aortic stenosis and coronary artery disease undergoing TAVI: implications for clinical indices of coronary stenosis severity

Yousif Ahmad - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation.

Mattia Lunardi - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Elevated FFR values at the acute moment in non-culprit vessels of STEMI patients due to decreased adenosine responsiveness: a comparison with the adenosine free iFR

Nina van der Hoeven - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Multi-vessel disease

Adenosine

Final 5-Year Outcomes of the REPRISE II Study: Long-term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Nicolas Dumonteil - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Derivation and Validation of Temperature Recovery Time as an Invasive Predictor of Microvascular Obstruction and Prognosis After ST-Segment Elevation Myocardial Infarction.

Annette Maznyczka - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Radial artery access and outcomes for left main stem PCI: an analysis of 19,482 cases from the British Cardiovascular Intervention Society national database

Tim Kinnaird - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved